Bengtsson M, Tötterman T H, Smedmyr B, Festin R, Oberg G, Simonsson B
Clinical Immunology Section, University Hospital, Uppsala, Sweden.
Leukemia. 1989 Jan;3(1):68-75.
The phenotypic reconstitution of lymphoid cells in the bone marrow and peripheral blood was examined prospectively in 27 patients who underwent autologous bone marrow transplantation (ABMT) for leukemia/lymphoma. Patterns of activation within NK and T cell subsets as well as T sub-subsets were studied with monoclonal antibodies in two- and three-color FACS analysis. NK-like cells (CD16+) were found to be increased in the peripheral blood and bone marrow after ABMT. The expression of two activation markers, 4F2 and HLA-DR, was sustainedly increased within this subset. High numbers of CD4+ and CD8+ T cells carrying surface HLA-DR were found early after ABMT both in blood and marrow. The T suppressor inducer cell sub-subset (CD45R+ CD4+) was severely depressed in both the blood and marrow 6-9 months post-ABMT. Using three-color FACS analysis, half of this T sub-subset was shown to express HLA-DR+. The levels of T suppressor effector-like cells (CD11+ CD8+) remained within the normal range in both peripheral blood and bone marrow during follow-up. The HLA-DR expression was elevated and equally distributed between the CD11- CD8+ and CD11+ CD8+ sub-subset cells. There was no major impact of marrow T cell purging or CMV carrier status on the phenotypic NK/T cell reconstitution. The present results provide an immune phenotypic basis for the suggested generation of anti-leukemic NK-like and T suppressor-like activity after ABMT.
对27例因白血病/淋巴瘤接受自体骨髓移植(ABMT)的患者进行前瞻性研究,观察其骨髓和外周血中淋巴细胞的表型重建情况。采用双色和三色荧光激活细胞分选术(FACS)分析,用单克隆抗体研究自然杀伤(NK)细胞亚群、T细胞亚群以及T细胞亚亚群的激活模式。发现ABMT后外周血和骨髓中的NK样细胞(CD16+)增加。该亚群中两种激活标志物4F2和人类白细胞抗原-DR(HLA-DR)的表达持续增加。ABMT后早期,血液和骨髓中均发现大量携带表面HLA-DR的CD4+和CD8+ T细胞。ABMT后6 - 9个月,血液和骨髓中的抑制性T诱导细胞亚亚群(CD45R+ CD4+)均严重减少。采用三色FACS分析显示,该T细胞亚亚群中有一半表达HLA-DR+。随访期间,外周血和骨髓中抑制性T效应样细胞(CD11+ CD8+)水平均保持在正常范围内。HLA-DR表达升高,且在CD11- CD8+和CD11+ CD8+亚亚群细胞之间均匀分布。骨髓T细胞清除或巨细胞病毒(CMV)携带状态对NK/T细胞表型重建无重大影响。本研究结果为ABMT后产生抗白血病NK样和抑制性T样活性提供了免疫表型基础。